Chronic Kidney Disease | CHOP Research Institute
 

Chronic Kidney Disease

Published on
Oct 9, 2023
Dr. Furth joins a legacy of influential scientific professionals who are shaping health research, practice, and policy.
Published on
Sep 6, 2023
Our September Featured Research Trainee, Arthur Lee, MD, studies untargeted metabolomic profiling to improve the lives of children with chronic kidney disease.
Published on
Mar 10, 2023
The National Kidney Foundation honored Susan Furth, MD, PhD, with the 2023 Excellence in Care Award.
Published on
Nov 7, 2022
The Penn-CHOP Kidney Innovation Center is a research collaborative aimed at accelerating discovery in lifespan kidney science.
Published on
Aug 5, 2022
This week’s In the News highlights PolicyLab’s second annual Impact Report, an FDA approval based on CHOP research, and a link between daycare and chronic lung disease effects in premature infants.

Dr. Denburg addresses fundamental limitations in understanding of skeletal morbidity in patients with chronic kidney disease, glomerular disease, and urinary stone disease, and develops resources to conduct observational research and trials to optimize health outcomes in these high risk populations.

E-mail:
denburgm [at] chop.edu

The Penn-CHOP Kidney Innovation Center is a research collaboration between the University of Pennsylvania and Children’s Hospital of Philadelphia focused on transforming patient care by early detection, prevention and treatment of kidney disease and its complications across the life course.

Dr. Xiao’s research focuses primarily on methodology and applications in clinical and genetic studies. She has extensive collaborative experience in developmental disabilities, metabolic disorders, EEG monitoring for seizure screening, chronic kidney disease, and juvenile spondyloarthritis.

E-mail:
xiaor [at] chop.edu

Investigating whether existing urinary mRNA and metabolite profiles, which are diagnostic and prognostic for early renal allograft injury in adults, can be validated in pediatric kidney transplant recipients.

Improving poor long-term health outcomes in both adolescents and young adults with either a kidney transplant or spina bifida.